Michael Exton Buys $50K of Lexicon Pharmaceuticals Inc (LXRX) — SEC Form 4, Nov 09, 2026
Open-Market Net Purchase · SEC Form 4
+$49,999
Equity position changed by +10.1%
Equity Position
328K sh
298,432 → 328,496
Equity Change
+10.1%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Michael Exton CIK 0002029249 |
Director
CEO
|
Michael Exton at Lexicon Pharmaceuticals Inc
Full insider history
Bought (12 mo)
$49,999
Sold (12 mo)
—
More from this insider at Lexicon Pharmaceuticals Inc
| 2026-03-03 | Exercise | — | View |
| 2026-02-17 | Award | — | View |
| 2025-02-18 | Award | — | View |
| 2024-07-08 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-11-06 | P - Purchase | 30,064 A | $1.66 | +$49,999 | 328,496 | Direct |
Footnotes (1)
- F1
- Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.63 to $1.67 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Show more
Related filings at Lexicon Pharmaceuticals Inc
Institutional Holders
13F holders · Jun 30, 2026
150
institutional managers reporting a position
Largest by reported value
- Artal Group S.A. $420M
- Fmr Llc $124M
- Siren, L.L.C. $106M
5%+ Holders · 13D/G
2 filers
-
Fmr Llc 15.0%
Other insiders at Lexicon Pharmaceuticals Inc
GET /v1/forms/4/0001062822-26-000130
API docs
View Original SEC Filing